Latest stories on ONCY
Oncolytics Biotech Data Strengthens Pelareorep’s Role in HPV-Driven Cancers
TipRanks63 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics reports updated data from Cohort 4 of Phase 1/2 GOBLET studt
The Fly58 · neutralproduct/pr
Oncolytics Showcases Pelareorep Phase 2 mCRC Study Plans
TipRanks56 · neutralproduct/pr
Oncolytics to present REO 033 trial in progress abstract at ESMO
The Fly56 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
Business Insider58 · neutralproduct/pr
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
GlobeNewswire58 · neutralproduct/pr
Oncolytics Biotech Updates GOBLET Gastrointestinal Cancer Study
TipRanks56 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
GlobeNewswire58 · neutralproduct/pr
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
Business Insider58 · neutralproduct/pr
Oncolytics should be bought amid recent weakness, says Lake Street
The Fly63 · neutralanalyst
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral
Oncolytics Biotech Extends Pelareorep Patent Protection Into Late 2040s
TipRanks63 · neutralproduct/pr
Oncolytics provides intellectual property portfolio update
The Fly53 · neutralproduct/pr
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
GlobeNewswire63 · neutralproduct/pr
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
Business Insider63 · neutralproduct/pr
Oncolytics Biotech Highlights Pelareorep’s Tumor-Activating Potential
TipRanks63 · neutralproduct/pr
Oncolytics announces publication of data on pelareorep in liver cancer
The Fly59 · neutralproduct/pr
ONCOLYTICS BIOTECH INC (ONCY) files 8-K
SEC 8-K50 · neutralgeneral